Parikh Asit's Form 4 filing
Phathom Pharmaceuticals, Inc. (PHAT) · filed Nov 8, 2023
- Accession no.
- 0001209191-23-054768
- Filed
- Nov 8, 2023
- Trade date
- Nov 6-8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $58.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parikh AsitCIK 0001796787 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $8.04 | +$8,040 | 48,500 | Direct | |
| Nov 7, 2023 | Common Stock | PPurchaseAcquired | +4,000 | $7.76 | +$31,040 | 52,500 | Direct | |
| Nov 8, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $7.80 | +$19,500 | 55,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.